Alterity Therapeutics Limited

ATHE · NASDAQ
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income$0-$7-$13$0
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$1$1$0
Change in WC$3-$2$3$2
Other Non-Cash-$6-$0$1-$6
Operating Cash Flow-$2-$8-$8-$4
Investing Activities
PP&E Inv.$0$0$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$8$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0-$0$0
Investing Cash Flow-$8$0-$0-$0
Financing Activities
Debt Repay.-$0-$0-$0-$0
Stock Issued$27$0$0$1
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$2$0$8-$0
Financing Cash Flow$25$0$8$1
Forex Effect-$0-$0$0-$0
Net Chg. in Cash$15-$5$0-$4
Supplemental Information
Beg. Cash$18$9$12$17
End Cash$33$5$13$12
Free Cash Flow-$2-$8-$8-$5